The purpose of this research is to develop the hydro-dynamically balanced delivery system of Cefixime Trihydrate for the localized action in the stomach, in the treatment of H.pylori mediated peptic ulcer. By applying wet granulation technique floating tablets of cefixime trihydra is prepare. Drug-Excipient compatibility study is performed by FTIR and DSC .Eudragit RS 100 polymer is use for maintaining drug release, % drug release, floating lag time and swelling index. The formulation developed using Cefixime trihydrate, Eudragit RS100, sodium bicarbonate gave floating lag time with a...

The book involves a research work towards developing a formulation of anti-osteoporotic drug, which has in-vitro dissolution profile similar to that of the Innovators' formulation. The patents for dosage form of Raloxifene will expire in late future. Hence, our target was to develop a dosage form as that of Innovator product to file an ANDA application. The present study involves the development of a non-infringing formula for an orally administrable immediate release tablet of the anti-osteoporotic drug with reproducible and robust process. The objectives of the research work included (i)...

L'objectif de cette recherche est de développer un système d'administration hydrodynamiquement équilibré de Céfixime Trihydrate pour une action localisée dans l'estomac, dans le traitement de l'ulcère gastrique médié par H.pylori. En appliquant la technique de granulation humide, des comprimés flottants de céfixime trihydraté sont préparés. Une étude de compatibilité entre le médicament et les excipients a été réalisée par FTIR et DSC. Le polymère Eudragit RS 100 a été utilisé pour maintenir la libération du médicament, le pourcentage de libération du médicament,...